Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Published (Last):||5 October 2016|
|PDF File Size:||8.84 Mb|
|ePub File Size:||7.85 Mb|
|Price:||Free* [*Free Regsitration Required]|
Four recombinajte had intracranial haemorrhage grade I, without sequelae at follow-up. Si continua navegando, consideramos que acepta su uso. From Monday to Friday from 9 a.
Nine issues are published each year, including mostly originals, reviews and consensus documents. SRJ is a prestige metric based on the idea that not all citations are the same.
March Pages ee24 Pages Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator.
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. This item has received. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice.
CiteScore measures average citations received per document published.
Recombinant tissue plasminogen activator for the management of intracardiac tiaular in newborns. In 4 patients complete resolution of the thrombus was achieved in a mean of 3. Previous article Next article. Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization.
You can change the settings or obtain more information by clicking here. Three patients received low molecular weight heparin prior to using rTPA. Print Send to a friend Export reference Tiisular Statistics. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact.
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two receding years.
Subscribe to our Newsletter. Continuing navigation will be considered as acceptance of this use. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.
There was a problem providing the content you requested
The patients included 4 males with a mean weight of gr. Subscriber If activsdor already have your login data, please click here. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.
Are you a health professional able to prescribe or dispense drugs?
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
They received between 1 to 5 cycles with rTPA. The aim of this study is to describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns.
There were no deaths or embolism.